{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:27:48Z","timestamp":1789846068469,"version":"4.0.1"},"reference-count":84,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2016.00151","type":"journal-article","created":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T05:43:27Z","timestamp":1461217407000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Cutaneous Leishmaniasis Vaccination: A Matter of Quality"],"prefix":"10.3389","volume":"7","author":[{"given":"Paula Mello","family":"De Luca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Beatriz Barreto","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,4,21]]},"reference":[{"key":"B1","author":"World Health Organization","year":"2016","journal-title":"Leishmaniasis Situation and Trends. Global Health Observatory"},{"key":"B2","first-page":"377","article-title":"Effectiveness of leishmanization in the control of cutaneous leishmaniasis","volume":"76","author":"Nadim","year":"1983","journal-title":"Bull Soc Pathol Exot Filiales"},{"key":"B3","doi-asserted-by":"publisher","first-page":"6759","DOI":"10.1016\/j.vaccine.2008.09.085","article-title":"First generation leishmaniasis vaccines: a review of field efficacy trials","volume":"26","author":"Noazin","year":"2008","journal-title":"Vaccine"},{"key":"B4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/00034983.1985.11811917","article-title":"An experimental vaccine against American dermal leishmaniasis: experience in the State of Esp\u00edrito Santo, Brazil","volume":"79","author":"Mayrink","year":"1985","journal-title":"Ann Trop Med Parasitol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.intimp.2011.05.008","article-title":"Vaccine candidates for leishmaniasis: a review","volume":"11","author":"Nagill","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"B6","first-page":"29","article-title":"Leishmaniasis in Brazil: XII. Observations on cross-immunity in monkeys and man infected with Leishmania mexicana mexicana, L. m. amazonensis, L. braziliensis braziliensis, L. b. guyanensis and L. b. panamensis","volume":"80","author":"Lainson","year":"1977","journal-title":"J Trop Med Hyg"},{"key":"B7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4269\/ajtmh.2004.71.297","article-title":"Cross-immunity experiments between different species or strains of Leishmania in rhesus macaques (Macaca mulatta)","volume":"71","author":"Porrozzi","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"B8","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1128\/CMR.6.3.230","article-title":"Leishmaniases of the New World: current concepts and implications for future research","volume":"6","author":"Grimaldi","year":"1993","journal-title":"Clin Microbiol Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1046\/j.1365-4362.2000.00969.x","article-title":"American tegumentary leishmaniasis (ATL) in Rio de Janeiro State, Brazil: main clinical and epidemiologic characteristics","volume":"39","author":"de Oliveira-Neto","year":"2000","journal-title":"Int J Dermatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e980","DOI":"10.1371\/journal.pntd.0000980","article-title":"Mucosal leishmaniasis caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon","volume":"5","author":"de Oliveira Guerra","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1590\/S1413-86702003000300009","article-title":"Post-kala-azar dermal leishmaniasis associated with AIDS","volume":"7","author":"Bittencourt","year":"2003","journal-title":"Braz J Infect Dis"},{"key":"B12","first-page":"319","article-title":"Disseminated cutaneous leishmaniasis in a field clinic in Bahia, Brazil: a report of eight cases","volume":"89","author":"Costa","year":"1986","journal-title":"J Trop Med Hyg"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1086\/345772","article-title":"Disseminated leishmaniasis: a new and emerging form of leishmaniasis observed in northeastern Brazil","volume":"186","author":"Turetz","year":"2002","journal-title":"J Infect Dis"},{"key":"B14","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4269\/ajtmh.1996.54.178","article-title":"Biological behavior of Leishmania amazonensis isolated from humans with cutaneous, mucosal, or visceral leishmaniasis in BALB\/c mice","volume":"54","author":"Almeida","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"B15","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1590\/S0074-02762005000500013","article-title":"Further observations on clinical, histopathological, and immunological features of borderline disseminated cutaneous leishmaniasis caused by Leishmania (Leishmania) amazonensis","volume":"100","author":"Silveira","year":"2005","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"B16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.0105-2896.2004.00190.x","article-title":"Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?","volume":"201","author":"McMahon-Pratt","year":"2004","journal-title":"Immunol Rev"},{"key":"B17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev.iy.13.040195.001055","article-title":"The regulation of immunity to Leishmania major","volume":"13","author":"Reiner","year":"1995","journal-title":"Annu Rev Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.imlet.2005.06.004","article-title":"Activated inflammatory T cells correlate with lesion size in human cutaneous leishmaniasis","volume":"101","author":"Antonelli","year":"2005","journal-title":"Immunol Lett"},{"key":"B19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cyto.2013.12.016","article-title":"The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of human tegumentary leishmaniasis","volume":"66","author":"Oliveira","year":"2014","journal-title":"Cytokine"},{"key":"B20","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/infdis\/175.3.737","article-title":"Leishmania aethiopica derived from diffuse leishmaniasis patients preferentially induce mRNA for interleukin-10 while those from localized leishmaniasis patients induce interferon-gamma","volume":"175","author":"Akuffo","year":"1997","journal-title":"J Infect Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/pim.12100","article-title":"Immunoregulation in human American leishmaniasis: balancing pathology and protection","volume":"36","author":"Gollob","year":"2014","journal-title":"Parasite Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00281-012-0350-8","article-title":"Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis","volume":"34","author":"Soong","year":"2012","journal-title":"Semin Immunopathol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"364","DOI":"10.4049\/jimmunol.165.1.364","article-title":"IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection","volume":"165","author":"Jones","year":"2000","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1128\/IAI.70.4.2151-2158.2002","article-title":"Early enhanced Th1 response after Leishmania amazonensis infection of C57BL\/6 interleukin-10-deficient mice does not lead to resolution of infection","volume":"70","author":"Jones","year":"2002","journal-title":"Infect Immun"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5827","DOI":"10.1128\/IAI.73.9.5827","article-title":"Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis","volume":"73","author":"de Moura","year":"2005","journal-title":"Infect Immun"},{"key":"B26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2334-7-7","article-title":"Resistance of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis to nitric oxide correlates with disease severity in tegumentary leishmaniasis","volume":"7","author":"Giudice","year":"2007","journal-title":"BMC Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/nm1108","article-title":"Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites","volume":"10","author":"Zaph","year":"2004","journal-title":"Nat Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1084\/jem.20142101","article-title":"Skin-resident memory CD4+ T cells enhance protection against Leishmania major infection","volume":"212","author":"Glennie","year":"2015","journal-title":"J Exp Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s10875-012-9788-7","article-title":"CCR7+ central and CCR7 effector memory CD4+ T cells in human cutaneous leishmaniasis","volume":"33","author":"Keshavarz Valian","year":"2013","journal-title":"J Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/1471-2334-13-529","article-title":"Immunologic response and memory T cells in subjects cured of tegumentary leishmaniasis","volume":"13","author":"Carvalho","year":"2013","journal-title":"BMC Infect Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1288\/00005537-198909000-00006","article-title":"Mucosal leishmaniasis in Brazil","volume":"99","author":"Zajtchuk","year":"1989","journal-title":"Laryngoscope"},{"key":"B34","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/0035-9203(90)90321-5","article-title":"Long-term follow-up of patients with Leishmania (Viannia) braziliensis infection and treated with Glucantime\u00ae","volume":"84","author":"Netto","year":"1990","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e81529","DOI":"10.1371\/journal.pone.0081529","article-title":"Leishmania braziliensis-reactive T cells are down-regulated in long-term cured cutaneous leishmaniasis, but the renewal capacity of T effector memory compartments is preserved","volume":"8","author":"Pereira-Carvalho","year":"2013","journal-title":"PLoS One"},{"key":"B36","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/ni832","article-title":"Distinct lineages of T(H)1 cells have differential capacities for memory cell generation in vivo","volume":"3","author":"Wu","year":"2002","journal-title":"Nat Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nri2355","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1365-2249.2011.04536.x","article-title":"Multifunctional CD4 +T cells in patients with American cutaneous leishmaniasis","volume":"167","author":"Macedo","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.trstmh.2005.04.002","article-title":"Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia","volume":"99","author":"V\u00e9lez","year":"2005","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.vaccine.2003.06.002","article-title":"Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis","volume":"22","author":"Armijos","year":"2004","journal-title":"Vaccine"},{"key":"B42","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00436-005-0008-8","article-title":"Intramuscular immunization with p36(LACK) DNA vaccine induces IFN-\u03b3 production but does not protect BALB\/c mice against Leishmania chagasi intravenous challenge","volume":"98","author":"Marques-Da-Silva","year":"2005","journal-title":"Parasitol Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e67453","DOI":"10.1371\/journal.pone.0067453","article-title":"Targeting Leishmania major antigens to dendritic cells in vivo induces protective immunity","volume":"8","author":"Matos","year":"2013","journal-title":"PLoS One"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e0004178","DOI":"10.1371\/journal.pntd.0004178","article-title":"The immunology of a healing response in cutaneous leishmaniasis treated with localized heat or systemic antimonial therapy","volume":"9","author":"Lakhal-Naouar","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e38859","DOI":"10.1371\/journal.pone.0038859","article-title":"High quality long-term CD4 + and CD8 + effector memory populations stimulated by DNA-LACK\/MVA-LACK regimen in Leishmania major BALB\/C model of infection","volume":"7","author":"S\u00e1nchez-Sampedro","year":"2012","journal-title":"PLoS One"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/j.vaccine.2013.02.025","article-title":"Heterologous priming-boosting with DNA and vaccinia virus expressing kinetoplastid membrane protein-11 induces potent cellular immune response and confers protection against infection with antimony resistant and sensitive strains of Leishmania (Leishmania) donovani","volume":"31","author":"Guha","year":"2013","journal-title":"Vaccine"},{"key":"B47","doi-asserted-by":"publisher","first-page":"202ra121","DOI":"10.1126\/scitranslmed.3006406","article-title":"Vaccination with Leishmania hemoglobin receptor-encoding DNA protects against visceral leishmaniasis","volume":"5","author":"Guha","year":"2013","journal-title":"Sci Transl Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.4049\/jimmunol.1202801","article-title":"Live attenuated Leishmania donovani p27 gene knockout parasites are nonpathogenic and elicit long-term protective immunity in BALB\/c mice","volume":"190","author":"Dey","year":"2013","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e30945","DOI":"10.1371\/journal.pone.0030945","article-title":"Immunization against Leishmania major infection using LACK- and IL-12-expressing Lactococcus lactis induces delay in footpad swelling","volume":"7","author":"Hugentobler","year":"2012","journal-title":"PLoS One"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1084\/jem.20092532","article-title":"IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform","volume":"207","author":"Darrah","year":"2010","journal-title":"J Exp Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3389\/fimmu.2014.00273","article-title":"Leishmania donovani nucleoside hydrolase terminal domains in cross-protective immunotherapy against Leishmania amazonensis murine infection","volume":"5","author":"Nico","year":"2014","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/j.1365-3024.2009.01116.x","article-title":"Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis","volume":"31","author":"Silveira","year":"2009","journal-title":"Parasite Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.molimm.2013.05.231","article-title":"Dogs immunized with LBSap vaccine displayed high levels of IL-12 and IL-10 cytokines and CCL4, CCL5 and CXCL8 chemokines in the dermis","volume":"56","author":"Vitoriano-Souza","year":"2013","journal-title":"Mol Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.vetpar.2013.09.011","article-title":"Cytokine and nitric oxide patterns in dogs immunized with LBSap vaccine, before and after experimental challenge with Leishmania chagasi plus saliva of Lutzomyia longipalpis","volume":"198","author":"Resende","year":"2013","journal-title":"Vet Parasitol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1756-3305-7-61","article-title":"LBSapSal-vaccinated dogs exhibit increased circulating T-lymphocyte subsets (CD4+ and CD8+) as well as a reduction of parasitism after challenge with Leishmania infantum plus salivary gland of Lutzomyia longipalpis","volume":"7","author":"Aguiar-Soares","year":"2014","journal-title":"Parasit Vectors"},{"key":"B56","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1590\/S0037-86822006000100003","article-title":"Immunotherapy, immunochemotherapy and chemotherapy for American cutaneous leishmaniasis treatment","volume":"39","author":"Mayrink","year":"2006","journal-title":"Rev Soc Bras Med Trop"},{"key":"B57","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0035-9203(03)90093-9","article-title":"Immunotherapy of American cutaneous leishmaniasis in Venezuela during the period 1990-99","volume":"97","author":"Convit","year":"2003","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"B58","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.parint.2014.07.010","article-title":"Short-term protection conferred by Leishvacin\u00ae against experimental Leishmania amazonensis infection in C57BL\/6 mice","volume":"63","author":"Carneiro","year":"2014","journal-title":"Parasitol Int"},{"key":"B59","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.exppara.2006.01.008","article-title":"Leishmania amazonensis: participation of regulatory T and B cells in the in vitro priming (PIV) of CBA\/J spleen cells susceptible response","volume":"113","author":"Veras","year":"2006","journal-title":"Exp Parasitol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1365-2249.2006.02995.x","article-title":"In vitro responses of human peripheral blood mononuclear cells to whole-cell, particulate and soluble extracts of Leishmania promastigotes","volume":"143","author":"Telino","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1007\/s00436-004-1193-6","article-title":"Immune responses associated with susceptibility of C57BL\/10 mice to Leishmania amazonensis","volume":"61","author":"Afonso","year":"1993","journal-title":"Infect Immun"},{"key":"B62","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/ng2053","article-title":"Comparative genomic analysis of three Leishmania species that cause diverse human disease","volume":"39","author":"Peacock","year":"2007","journal-title":"Nat Genet"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1093\/nar\/gkr834","article-title":"Genome sequencing of the lizard parasite Leishmania tarentolae reveals loss of genes associated to the intracellular stage of human pathogenic species","volume":"40","author":"Raymond","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1101\/gr.123430.111","article-title":"Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance","volume":"21","author":"Downing","year":"2011","journal-title":"Genome Res"},{"key":"B65","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1093\/dnares\/dst031","article-title":"The genome sequence of Leishmania (Leishmania) amazonensis: functional annotation and extended analysis of gene models","volume":"20","author":"Real","year":"2013","journal-title":"DNA Res"},{"key":"B66","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00436-004-1193-6","article-title":"Immune response induced by New World Leishmania species in C57BL\/6 mice","volume":"94","author":"Maioli","year":"2004","journal-title":"Parasitol Res"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.4049\/jimmunol.178.2.1077","article-title":"Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages","volume":"178","author":"Yang","year":"2007","journal-title":"J Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e871","DOI":"10.1371\/journal.pntd.0000871","article-title":"CD8 cells of patients with diffuse cutaneous leishmaniasis display functional exhaustion: the latter is reversed, in vitro, by TLR2 agonists","volume":"4","author":"Hern\u00e1ndez-Ruiz","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/eji.201141926","article-title":"Leishmania amazonensis impairs DC function by inhibiting CD40 expression via A2B adenosine receptor activation","volume":"42","author":"Figueiredo","year":"2012","journal-title":"Eur J Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fimmu.2012.00058","article-title":"Subversion and utilization of host innate defense by Leishmania amazonensis","volume":"3","author":"Soong","year":"2012","journal-title":"Front Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"3966","DOI":"10.1128\/IAI.00770-13","article-title":"Leishmania amazonensis amastigotes trigger neutrophil activation but resist neutrophil microbicidal mechanisms","volume":"81","author":"Carlsen","year":"2013","journal-title":"Infect Immun"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e3000","DOI":"10.1371\/journal.pntd.0003000","article-title":"Leishmania amazonensis amastigotes highly express a tryparedoxin peroxidase isoform that increases parasite resistance to macrophage antimicrobial defenses and fosters parasite virulence","volume":"8","author":"Henard","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"B73","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1590\/S0074-02762012000200014","article-title":"Kinetoplastid membrane protein-11 exacerbates infection with Leishmania amazonensis in murine macrophages","volume":"107","author":"Lacerda","year":"2012","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"B74","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1017\/S0031182006001831","article-title":"Leishmania vaccines: progress and problems","volume":"133","author":"Kedzierski","year":"2006","journal-title":"Parasitology"},{"key":"B75","doi-asserted-by":"publisher","first-page":"5226","DOI":"10.4049\/jimmunol.167.9.5226","article-title":"Sandfly maxadilan exacerbates infection with Leishmania major and vaccinating against it protects against L. major infection","volume":"167","author":"Morris","year":"2001","journal-title":"J Immunol"},{"key":"B76","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.4049\/jimmunol.161.10.5571","article-title":"Phlebotomus papatasi sand fly salivary gland lysate down-regulates a Th1, but up-regulates a Th2, response in mice infected with Leishmania major","volume":"161","author":"Mbow","year":"1998","journal-title":"J Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"e712","DOI":"10.1371\/journal.pntd.0000712","article-title":"Immunity to Lutzomyia intermedia saliva modulates the inflammatory environment induced by Leishmania braziliensis","volume":"6","author":"de Moura","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1128\/IAI.72.3.1240-1247.2004","article-title":"Sand fly saliva enhances Leishmania amazonensis infection by modulating interleukin-10 production","volume":"72","author":"Norsworthy","year":"2004","journal-title":"Infect Immun"},{"key":"B79","doi-asserted-by":"publisher","first-page":"e2627","DOI":"10.1371\/journal.pntd.0002627","article-title":"Repeated exposure to Lutzomyia intermedia sand fly saliva induces local expression of interferon-inducible genes both at the site of injection in mice and in human blood","volume":"8","author":"Weinkopff","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1126\/science.290.5495.1351","article-title":"Protection against cutaneous leishmaniasis resulting from bites of uninfected sand flies","volume":"290","author":"Kamhawi","year":"2000","journal-title":"Science"},{"key":"B81","doi-asserted-by":"publisher","first-page":"e2242","DOI":"10.1371\/journal.pntd.0002242","article-title":"Functional transcriptomics of wild-caught Lutzomyia intermedia salivary glands: identification of a protective salivary protein against Leishmania braziliensis infection","volume":"7","author":"de Moura","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e2781","DOI":"10.1371\/journal.pntd.0002781","article-title":"Characterization of the early inflammatory infiltrate at the feeding site of infected sand flies in mice protected from vector-transmitted Leishmania major by exposure to uninfected bites","volume":"8","author":"Teixeira","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"B83","doi-asserted-by":"publisher","first-page":"290ra90","DOI":"10.1126\/scitranslmed.aaa3043","article-title":"A sand fly salivary protein vaccine shows efficacy against vector-transmitted cutaneous leishmaniasis in nonhuman primates","volume":"7","author":"Oliveira","year":"2015","journal-title":"Sci Transl Med"},{"key":"B84","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1471-2180-13-102","article-title":"Dual effect of Lutzomyia longipalpis saliva on Leishmania braziliensis infection is mediated by distinct saliva-induced cellular recruitment into BALB\/c mice ear","volume":"13","author":"Carregaro","year":"2013","journal-title":"BMC Microbiol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T21:55:36Z","timestamp":1718488536000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fimmu.2016.00151\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,21]]},"references-count":84,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2016.00151","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,21]]}}}